| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.164 | 13.394 | 13.258 | 10.132 | 7.923 | 7.174 | 9.097 | 10.382 | 12.225 | 10.414 |
| Total Income - EUR | 15.553 | 13.682 | 13.350 | 11.469 | 9.599 | 8.605 | 10.822 | 12.778 | 12.734 | 12.185 |
| Total Expenses - EUR | 5.491 | 3.621 | 3.985 | 5.229 | 5.695 | 3.699 | 4.571 | 6.541 | 15.155 | 14.677 |
| Gross Profit/Loss - EUR | 10.062 | 10.061 | 9.366 | 6.240 | 3.904 | 4.906 | 6.251 | 6.237 | -2.421 | -2.492 |
| Net Profit/Loss - EUR | 8.831 | 9.651 | 8.965 | 5.936 | 3.666 | 4.705 | 5.983 | 5.982 | -2.548 | -2.598 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Viofarm Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.537 | 22.628 | 21.589 | 20.548 | 19.518 | 18.528 | 17.510 | 16.956 | 16.854 | 16.397 |
| Current Assets | 80.592 | 30.899 | 4.377 | 10.086 | 1.410 | 2.111 | 3.943 | 7.131 | 3.947 | 3.209 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 150 | 0 | 403 | 721 | 739 | 694 | 1.084 | 1.037 | 596 | 1.048 |
| Cash | 16.401 | 8.236 | 3.974 | 9.365 | 671 | 1.417 | 2.859 | 6.094 | 3.351 | 2.161 |
| Shareholders Funds | 54.088 | 26.420 | 25.450 | 22.118 | 19.536 | 20.274 | 21.206 | 22.985 | 17.051 | 14.358 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50.041 | 27.108 | 516 | 8.516 | 1.392 | 365 | 246 | 1.102 | 3.750 | 5.248 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Viofarm Impex Srl